225 related articles for article (PubMed ID: 15967085)
1. Papillary thyroid cancer: medical management and follow-up.
Kloos RT
Curr Treat Options Oncol; 2005 Jul; 6(4):323-38. PubMed ID: 15967085
[TBL] [Abstract][Full Text] [Related]
2. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.
Schlumberger M; Leboulleux S; Catargi B; Deandreis D; Zerdoud S; Bardet S; Rusu D; Godbert Y; Buffet C; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Toubert ME; Kelly A; Benhamou E; Borget I
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):618-626. PubMed ID: 29807824
[TBL] [Abstract][Full Text] [Related]
3. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer.
Herman AE; Argersinger DP; Maksutova M; Morgan T; Hughes DT
Endocr Pract; 2024 Feb; 30(2):89-94. PubMed ID: 37926368
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer.
Choi S; Na CJ; Kim J; Han YH; Kim HK; Jeong HJ; Sohn MH; Lim ST
Nucl Med Mol Imaging; 2015 Jun; 49(2):115-21. PubMed ID: 26085856
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
Gambale C; Prete A; Contartese L; Torregrossa L; Bianchi F; Molinaro E; Materazzi G; Elisei R; Matrone A
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855417
[TBL] [Abstract][Full Text] [Related]
6. Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study.
Barreto L; Ferreira DCG; Corrente JE; Soares CSP; Oliveira CC; Terra SA; Moriguchi SM; Koga KH; Tagliarini JV; da Silva Mazeto GMF
Hormones (Athens); 2024 Mar; 23(1):97-106. PubMed ID: 38015413
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cancer presentation and treatment in the United States.
Enewold L; Harlan LC; Stevens JL; Sharon E
Ann Surg Oncol; 2015; 22(6):1789-97. PubMed ID: 25361888
[TBL] [Abstract][Full Text] [Related]
8. False diagnosis of recurrent thyroid carcinoma: the importance of testing for heterophile antibodies.
Guastapaglia L; Chiamolera MI; Viana Lima Junior J; Ferrer CMF; Godoy Viana L; Veiga Chang C; Andrade Siqueira R; Monteiro Barros Maciel R; Henriques Vieira JG; Biscolla RPM
Arch Endocrinol Metab; 2024 Mar; 68():e230115. PubMed ID: 38456952
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Effectiveness of Triiodothyronine Suppression and Withdrawal Versus Thyrogen Injections in Thyroid Cancer Assessments.
Abdulhameed NM; Janabi MA
Cureus; 2023 Dec; 15(12):e51061. PubMed ID: 38269223
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.
Oh JR; Ahn BC; Jeong SY; Lee SW; Lee J
Nucl Med Mol Imaging; 2015 Sep; 49(3):174-81. PubMed ID: 26279690
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer.
Giovanella L; D'Aurizio F; Petranović Ovčariček P; Görges R
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38730992
[TBL] [Abstract][Full Text] [Related]
12. Favorable long term results in patients with small differentiated thyroid cancer not treated with radioiodine.
Busnardo B; Girelli ME; Rubello D; Pelizzo MR; Simioni N; Nacamulli D
Tumori; 1989 Feb; 75(1):57-9. PubMed ID: 2711476
[TBL] [Abstract][Full Text] [Related]
13. Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.
Dotan I; Roche PJ; Paliouras M; Mitmaker EJ; Trifiro MA
PLoS One; 2016; 11(2):e0149723. PubMed ID: 26901566
[TBL] [Abstract][Full Text] [Related]
14. Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin.
Pang YL; Wang YP; Cheng K
Evid Based Complement Alternat Med; 2022; 2022():9557061. PubMed ID: 35958920
[TBL] [Abstract][Full Text] [Related]
15. Complete diaphysis resorption of the femur: A case report in a metastatic papillary thyroid cancer.
Suwardjo S; Avanti WS; Dwianingsih EK; Harahap WA; Anwar SL
Ann Med Surg (Lond); 2020 Dec; 60():614-618. PubMed ID: 33304574
[TBL] [Abstract][Full Text] [Related]
16. Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma.
Toyoshima MTK; Domingues RB; Soares IC; Danilovic DLS; Amorim LC; Cavalcante ERC; Antonacio FF; Roitberg FSR; Hoff AO
Arch Endocrinol Metab; 2021 Nov; 65(4):495-499. PubMed ID: 34283905
[TBL] [Abstract][Full Text] [Related]
17. Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery.
Shuai JH; Leng ZF; Wang P; Ji YC
World J Clin Cases; 2023 Sep; 11(27):6407-6414. PubMed ID: 37900235
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of Radioiodine Uptake by Pulmonary Metastasis of Papillary Thyroid Carcinoma Treated with Dabrafenib and Trametinib.
Malja E; Kandathil A; Peng F
Nucl Med Mol Imaging; 2024 Apr; 58(2):92-94. PubMed ID: 38510823
[TBL] [Abstract][Full Text] [Related]
19. Summary and update on the management of differentiated thyroid cancer in 2023.
Raymond P; Klein M; Borson-Chazot F
Ann Endocrinol (Paris); 2024 Apr; 85(2):110-117. PubMed ID: 38316254
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
